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Abstract 
Staphylococcus aureus causes a wide variety of infections including osteomyelitis, endocarditis, 
and necrotizing pneumonia. It has been known for decades that S. aureus is auxotrophic for many 
amino acids including arginine.  However, we discovered that after extended incubation, S. aureus 
can be trained to grow in a defined media lacking arginine. We demonstrate here that this delayed 
growth is due to the selection of mutations in ahrC, a transcriptional regulator of arginine 
biosynthesis. A mutation in ahrC mediates the growth of S. aureus in CDM-R by facilitating the 
biosynthesis of arginine via proline. Mutations in putA and argGH halt the growth of the JE2 ahrC 
mutant while a mutation in argDCJB did not. In addition, Liquid Chromatography with tandem 
mass spectrometry (LC-MS/MS) analysis showed that 13C5-labelled arginine was detected in the 
JE2 ahrC mutant when grown in the presence of 13C5-labelled proline and not of13C5-labelled 
glutamate further confirming that proline is the precursor of arginine. Furthermore, our 
transcriptional analysis results demonstrate that AhrC in S. aureus functions to primarily repress 
argGH 
 and arcB1 allowing for arginine biosynthesis via proline. Although the mechanism of arginine 
biosynthesis regulation was shown to be conserved among species, our data demonstrate that AhrC 
in S. aureus functions to regulate arginine biosynthesis differently, with the biosynthesis being 
mediated through the urea cycle using proline as a precursor instead of the highly conserved and 
well-characterized glutamate pathway which was shown to be inactive in-vitro 
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1. Chapter 1: Introduction  
Staphylococcus aureus is a common cause of community-associated and hospital-acquired 
infections. Clinical manifestations can range from skin and soft tissue infections to more severe 
conditions such as bacteremia, osteomyelitis, endocarditis, and necrotizing pneumonia[1]. The 
ability of S. aureus to infect multiple organ systems was initially attributed to the acquisition of 
multiple of virulence factors. However, it was documented that S. aureus has evolved to 
metabolically adapt to cause invasive infections. Therefore, to thrive in different environments, S. 
aureus must scavenge nutrients and coordinate nitrogen and carbon usage. It has been documented 
that glycolysis is essential for S. aureus virulence and tissue invasion[2]. However, within 
staphylococcal abscesses, glucose, a preferred carbon source for S. aureus is limited. Hence, upon 
depletion of glucose, S. aureus must derive carbon and nitrogen source from the catabolism of 
amino acids such as glutamate, proline, and arginine[3]. These three are the primary 
interconvertible carbon source in a glucose depleted environment. Proline, as well as glutamate, 
are abundant amino acids within the abscess. In contrast, arginine is depleted at the site of infection 
due to inflammatory response and the upregulation of host iNOS and arginase, both requiring 
arginine as a substrate. Mutation in the arginine biosynthetic pathway attenuated virulence of S. 
aureus in vivo [4, 5]. Therefore, it is important to investigate arginine biosynthesis and its regulation 
in S. aureus. Understanding how S. aureus accommodates for arginine depletion in vivo is 
important and provides insights on host-pathogen interaction and how the pathogen proliferates 
despite the hostile environment. 
 S. aureus harbors the genes encoding the arginine biosynthetic pathway argJBCDFGH 
responsible for synthesizing arginine from glutamate[6]. Biosynthesis of arginine from glutamate 
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is a highly conserved and well-characterized pathway adopted by multiple bacteria, including 
Bacillus subtilis, Salmonella enterica serovar Typhimurium, and Escherichia coli [7, 8]. However, 
studies from Nuxoll et al. documented that in S. aureus arginine is synthesized from proline rather 
than glutamate. This study also documented that the arginine biosynthetic pathway is regulated by 
carbon catabolite repression (CCR) through the activity of carbon catabolite protein A, CcpA. 
Indeed, a ccpA mutant could grow on a media lacking arginine. However, mutations in putA,argG 
and argH, but not argC, completely abrogated the growth of the ccpA mutant implicating that the 
glutamate pathway is inactive in-vitro[4]. In agreement with the previous observations, Halsey et 
al. showed that putA and argGH transcription are upregulated in a ccpA mutant further confirming 
that arginine biosynthesis is regulated by CCR and that the production of arginine from proline is 
responsible for the phenotype of the ccpA mutant when grown in a media lacking arginine[3]. 
Hence, based on these studies, one would expect that the growth of S. aureus in media lacking 
glucose and arginine (CDM-R) will be induced since CCR and arginine transcription repression 
will be alleviated. Surprisingly, S. aureus still exhibits arginine auxotrophy when grown in CDM-
R. However, growth can be selected after extended incubation. This delayed growth is due to the 
selection of mutations in ahrC which encodes for a transcriptional regulator of arginine biosynthetic 
genes. In Bacillus subtilis, AhrC exerts regulation through the binding to operator site called ARG 
box found upstream of arginine biosynthetic genes mediating their repression in presence of 
arginine[9]. Experimental evidence indicates that this mechanism of regulation is conserved among 
gram-positive as well as gram-negative bacteria[10, 11]. However, little is known about how AhrC 
regulates arginine biosynthesis in S. aureus. This thesis will discuss the importance of proline as 
an alternative precursor for arginine biosynthesis and the function of AhrC in regulating arginine 
metabolism in S. aureus. 
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A historical perspective of arginine biosynthesis: Fundamental change and findings. 
Early studies assessing the arginine biosynthesis pathway have brought forth many fundamental 
changes in the perspective of scientists regarding the regulation of biochemical pathways. Crucial 
experiments were conducted, which contributed to significant knowledge in the field and brought 
forward new scientific concepts. In 1953, Henry Vogel observed that arginine is an antagonist for 
the enzyme N-acetylornithinase [12]. In 1957, at the McCollum Pratt Symposium, Vogel explained 
these data using the term “enzyme repression.” The substance mediating the inhibition was called 
the “represser” (spelling now changed to repressor). Since then, the term repressor is an accepted 
term in the scientific field as the molecule that inhibits enzyme activity [13]. The experiments 
carried out by Werner K. Maas in 1957 demonstrating the kinetics of ornithine 
carbamoyltransferase demonstrated that both exogenous and endogenous arginine regulate the rate 
of enzyme synthesis in the metabolic pathway [14]. To further elucidate the mechanism behind 
enzymatic repression, in 1959, Werner isolated E. coli K12 mutants resistant to canavanine, which 
is an arginine analog that competes for protein synthesis. These mutants overcame the inhibition 
caused by canavanine and were then derepressed for multiple arginine anabolic enzymes. Werner 
had mapped the mutation present in the above mutants and termed the mutated gene as an arginine 
repressor (argR). Werner suggested that argR regulates the expression of an “aporepressor” with 
arginine acting as the “corepressor” [15, 16]. At the 1961 Cold Spring Harbor Symposium, 
Francois Jacob and Jacques Monod documented two important concepts, the operon model and 
mRNA [17]. In the same symposium, Werner and Luigi Gorini demonstrated that the arginine 
biosynthetic genes are scattered across the chromosome, and yet they are regulated by the same 
regulatory element [16-18]. Later in 1964, Werner and John Clark stated that the repressor argR 
negatively regulates the arginine biosynthetic genes. Thus, they together coined the term regulon, 
which describes the phenomenon where a single regulatory molecule controls a set of unlinked 
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genes, as seen in arginine biosynthetic enzymes [19]. These findings have therefore changed the 
perspective regarding biochemical regulation and have immensely contributed to the establishment 
of the molecular biology field.  
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Arginine metabolism and bacterial pathogenesis 
S. aureus catabolizes arginine through the highly conserved arginine deiminase (ADI) 
pathway. Catabolism of arginine through ADI generates ornithine, ammonia, and carbon dioxide 
and 1 ATP. ADI consists of three enzymes encoded on the arc operon: arginine deiminase (ArcA), 
ornithine carbamoyltransferase (ArcB), and carbamate kinase (ArcC). Recent evidence 
documented that methicillin-resistant community-associated S. aureus (CA-MRSA) has acquired 
a second copy of the arc operon found on the arginine catabolic mobile element (ACME) which 
was shown to contribute to the ability of this particular strain to thrive within acidic environments 
and cause skin and soft tissue infections (SSTI) [20].  
Furthermore, arginine serves as a substrate for the NO synthase enzyme (NOS) in S. aureus 
resulting in nitric oxide (NO) production. It was demonstrated that NOS functions in hydrogen 
peroxide resistance, biofilm formation, and toxin production. Also, evidence has shown that 
endogenous nitric oxide mediates S.aureus daptomycin resistance, facilitates nasal colonization, 
and promotes protection from oxidative stress [21]. 
In conclusion, arginine is a part of an extensive metabolic network. It functions in pH 
homeostasis, serves as a nitrogen and carbon source and substrate for multiple enzymes all 
contributing to the virulence of pathogen within a particular host and affecting S. aureus physiology 
and host interactions[22, 23]. 
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Arginine biosynthesis in Staphylococcus aureus  
The arginine biosynthetic pathway from glutamate is a highly conserved and well-
characterized pathway found among a wide array of bacteria, including Bacillus subtilis, 
Salmonella enterica serovar Typhimurium, and Escherichia coli. Genome sequencing has 
demonstrated that S. aureus harbors the arginine biosynthetic genes argJBCDFGH; these genes 
encode the enzymes responsible for synthesizing arginine from glutamate (Fig.1.1). Although S. 
aureus harbors the biosynthetic capability to synthesize arginine, it still exhibits auxotrophy for 
arginine when grown on a complex laboratory media. Nuxoll et al. demonstrated that S. aureus 
arginine biosynthesis is under carbon catabolite repression and that proline serves as a precursor 
for arginine biosynthesis instead of glutamate (Fig.1.2). The highly conserved glutamate pathway 
was shown to be inactive under in-vitro conditions.  It is still unclear when or if S. aureus 
derepresses the glutamate biosynthetic pathway or if there is any niche where this pathway is 
activated during host invasion. The enzymes' names participating in arginine biosynthesis along 
with their EC number and gene symbol are illustrated in Table.1.1 
  Further, S. aureus encodes a set of virulence factors that enables it to destroy host tissue 
[24]. Among these, SspB and SspA, are proteases that degrade collagen, a proline-rich protein 
found in animals [25-28]. Degradation of collagen results in the release of free proline, which can 
be used as a substrate for arginine production. Thus, this mechanism adopted by S. aureus might 
be beneficial; since collagen is an abundant protein surrounding the fibrotic wall of a 
staphylococcal abscess and its use to produce arginine exhibits that S. aureus metabolically adapts 
and evolves to acquire nutrients that are readily available at the site of infection to support its 
growth. 
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Figure 1.1 Arginine Biosynthesis via Glutamate 
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Figure 1.2 Arginine biosynthesis via urea cycle in S.  aureus. 
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Table 1.1 Enzyme name with the corresponding EC number and their gene symbol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enzyme Name EC number Gene symbol 
Glutamate N-acetyltransferase/amino-
acid acetyltransferase 
EC:2.3.1.35 2.3.1.1 argJ 
N-Acetylglutamate kinase EC 2.7.2.8 argB 
N-Acetylglutamylphosphate reductase EC 1.2.1.38 argC 
N-Acetylornithine aminotransferase 
 
EC 2.6.1.11 argD 
Ornithine carbamoyltransferase EC:2.1.3.3 arcB1,arcB2,argF 
Argininosuccinate synthetase 
 
EC 6.3.4.5 argG 
Argininosuccinase EC 4.3.2.1 argH 
Arginase EC:3.5.3.1 rocF 
Proline dehydrogenase EC:1.5.5.2 putA 
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Regulation of arginine biosynthesis in Staphylococcus aureus. 
Transcriptional regulation of arginine biosynthesis was first studied in Escherichia coli where it 
was disclosed that ArgR, an L-arginine dependent repressor,  represses transcription of arginine 
biosynthetic genes by binding to the DNA operator sites found upstream of the arg genes, 
overlapping the promoter sequence. Each operator site, known as an ARG box, consists of a pair 
of 18 bp palindromic sequences (separated by 2-3 bp) [10, 27]. In Bacillus subtilis, AhrC, an ArgR 
homologue, also represses the arginine biosynthetic pathway in presence of arginine, but in contrast 
to the mechanism of regulation in E. coli, additional transcriptional activation of arginine catabolic 
genes is mediated by AhrC[9]. AhrC forms a hexamer, a dimer of trimers, through oligomerization 
of its C-terminal domain. The dimer-trimer interface results in the formation of the arginine binding 
pocket consisting of Gln104, Asp111, Thr121, Cys123, Asp125, and Asp126.  The N-terminal 
domain has a DNA binding motif, this motif was shown to be part of the winged helix-turn-helix 
family (wHTH). In the presence of arginine, AhrC binds to the operator sequence, known as ARG 
box, located within the promoter of argC and argG, repressing the transcription of the arginine 
biosynthetic genes[9]. 
S.aureus encodes three ArgR-type transcriptional regulators, ArgR1 and ArgR2, and AhrC. ArgR1 
and ArgR2 are encoded by argR1 and argR2 genes, respectively.  argR1 belongs to the native ADI 
operon while argR2 is a monocistronic unit of the second ADI operon encoded by the acquired 
arginine catabolic mobile element (ACME). ahrC is co-transcribed with the DNA recombination 
gene, recN, both found in the same operon on the chromosome[28]. Halsey et. al demonstrated that 
ArgrR1 activates the transcription of putA when carbon catabolite repression is alleviated while 
AhrC represses the transcription of rocA and rocD. These data together suggest that both ArgR1 
and AhrC regulate arginine biosynthesis via proline. However, unlike other bacteria, where the 
regulation of arginine biosynthesis is extensively studied and well-characterized, little is known 
how S. aureus transcriptionally regulates arginine biosynthesis. As previously mentioned, S. aureus 
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has adopted a novel proline catabolic pathway to synthesize arginine instead of using the glutamate 
canonical pathway. Also, S. aureus harbors three transcriptional regulators instead of one, imposing 
limitations in studying the regulation of the arginine biosynthetic pathway. Despite the conservation 
of the mechanism of regulation among different species, S.aureus appears to regulate arginine 
biosynthesis differently, therefore, more studies are needed to investigate how S.aureus functions 
to regulate arginine biosynthesis in the case of arginine starvation. 
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2. Chapter 2: Materials and Methods 
 
Bacterial strains and culture Conditions 
All strains used in this study are listed in Table. 2.1. Defined bursa aurealis transposon mutants 
were obtained from the Nebraska Transposon Mutant Library and backcrossed to JE2 using 
Ф11[29]. JE2 ahrC markless deletion mutant ΔahrC was generated as described in[3].JE2 ahrC 
mutant was isolated after 18-24 hours growth of JE2 in complete defined media lacking arginine 
(CDM-R). Following the delayed growth on CDM-R, colonies were selected on Tryptic Soy Agar 
(TSA) and growth was assessed in CDM-R. The colonies that exhibited growth in CDM-R were 
sent for whole-genome sequencing. Whole-genome sequencing results are illustrated in Table 2.1 
Bacterial cultures were grown overnight in 5 mL Tryptic Soy Broth at 37°C with shaking at 250 
rpm. Overnight cultures were washed with phosphate-buffered saline (PBS) and inoculated to an 
optical density at 600 nm (OD600) of 0.05. Growth curves were performed in CDM and CDM-R 
with no glucose added[30] in 96-well plate in the Tecan Device at 37°C with shaking at 250 rpm. 
RNA isolation and RT-qPCR analysis 
Cultures of S. aureus JE2, JE2 ahrC and ΔahrC were grown overnight in 3ml CDM at 37°C with 
shaking at 250 rpm. Overnight cultures were inoculated to an OD600 of 0.05 into 25 ml of CDM or 
CDM-R into 250 mL flask (1:10 volume to flask ratio). Cells were grown to exponential phase and 
were collected when they reach an OD600 = 0.4-0.8. 6 mL of Qiagen RNAprotect Bacteria reagent 
was added to 3 mL of collected culture. Following, Cells were incubated for 5 minutes at room 
temperature, pelleted by centrifugation for 10 minutes at full speed. Pellet was resuspended in 185 
uL lysis buffer, followed by 15 uL of proteinase K. Next, samples were incubated at rotating 
platform shaker at room temperature for 10 min then resuspended in  700 uL RLT buffer with 1% 
-mercaptoethanol. Suspensions were transferred to lysing matrix B tubes (MP Biomedicals) and 
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processed in an FP120 FastPrep cell disrupter (MP Biomedicals) for 45 seconds at a setting of 6.0. 
760 uL of the supernatant was transferred into a new tube containing 590 uL of 80% ethanol. The 
samples were then processed using an RNeasy mini kit, according to manufactures instructions 
(Qiagen, Inc.). cDNA was generated using SuperScript™ IV VILO™ Master Mix with 
ezDNase™ Enzyme with 1 pg to 2.5 µg total RNA in each 10 uL reaction. 
All qPCRs were performed in 20μl reactions (10μl Taq DNA polymerase MasterMix 
(ThermoFisher), 1μl of 10μM primer sets, 4μl H2O, 5μl template cDNA). Standards and samples 
were assayed in duplicate in the LightCycler©480 device. All primer-probe set used are listed in 
Table. 2.3 and 2.4 
Liquid Chromatography with tandem mass spectrometry (LC-MS/MS). 
LC-MS/MS separation and quantitation were carried out using XBridge Amide 3.5 µm (2.1 x 100 
mm) column procured from Waters. Mobile phase A was 10 mM ammonium acetate and 10 mM 
ammonium hydroxide in water + 5% acetonitrile whereas mobile phase B contains 100% 
acetonitrile. The flow rate was 0.4mL/min with a gradient mode of mobile phases. The column was 
maintained at 40 ℃. Detection of metabolites was carried out using QTRAP 6500 (Sciex) in 
multiple reaction mode (MRM). All the labeled metabolites such as canonical and non-canonical 
amino acid standard mixtures, 13C-arginine, 13C-glutamate and 13C-proline were purchased from 
Cambridge Isotopes Inc, USA. 
Transduction of putA:: NΣ, argH:: NΣ and argC:: NΣ into JE2 ahrC mutant and 
ΔahrC background. 
Ф11 transducing lysates were prepared from defined JE2 bursa aurealis mutants with insertions in 
the putA, argH, argC. These bursa aurealis mutations conferring erythromycin resistance were 
transduced into JE2 ahrC and ΔahrC. Mutants were selected on TSA containing 10 μg/ml 
erythromycin. Subsequently, Insertions of putA,argH and argC were confirmed by PCR.  
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Table 2.1 Bacterial Strains used in this study  
Bacterial Strains Phenotypes Source 
S. aureus JE2 LAC cured of all 3 native plasmids [29] 
S. aureus putA:: NΣ bursa aurealis mutation in proline 
dehydrogenase 
[29] 
S. aureus argH:: NΣ bursa aurealis mutation argininosuccinase [29] 
S. aureus argC:: NΣ bursa aurealis mutation acetylglutamylphosphate 
reductase 
[29] 
JE2 ahrC mutant Mutant selected after extended growth in CDM-
R 
This study 
ΔahrC Markerless deletion in SAUS200_1469, 
arginine repressor 
[3] 
S. aureus JE2 
argR1::ΝΣ 
bursa aurealis mutation in 
SAUSA300_2571, arginine repressor 
[3] 
S. aureus JE2 
argR2:: ΝΣ 
bursa aurealis mutation in 
SAUSA300_0066, arginine repressor 
[3] 
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Table 2.2 Whole Genome Sequencig results 
Isolate Start Change Amino 
Acid 
Change 
Protein 
Effect 
Product 
1 146215 C -> A 
 
Truncation FIG01107877: 
hypothetical protein 
1 963762 T -> C L -> S Substitution ATP-dependent 
nuclease, subunit B 
1 1655458 C -> A 
 
Truncation Late competence 
protein ComGF, 
access of DNA to 
ComEA, FIG017774 
1 2524007 G -> T P -> T Substitution Nitrite reductase 
[NAD(P)H] large 
subunit (EC 1.7.1.4) 
1 2784181 A -> G 
  
Arc promoter 
2 1358107 A -> C 
   
2 2784181 A -> G 
  
Arc promoter 
4 447901 C -> T H -> Y Substitution Exotoxin 7 
4 2784181 A -> G 
  
Arc promoter 
8 2784202 A -> T 
  
Arc promoter 
8 2784204 -A 
  
Arc promoter 
17 1639590 C -> A C -> F Substitution AhrC, repressor of arg 
regulon 
18 804659 A -> T L -> I Substitution Di/tripeptide permease 
YjdL 
18 1564471 C -> T G -> D Substitution Phage lysin, N-
acetylmuramoyl-L-
alanine amidase (EC 
3.5.1.28) 
18 2711153 T -> G I -> L Substitution Acyltransferase 
18 2784204 A -> T 
  
Arc promoter 
21 1550253 C -> A P -> H Substitution L-asparaginase (EC 
3.5.1.1) 
21 1561036 T -> A 
   
21 1639949 T -> A K -> N Substitution Arginine pathway 
regulatory protein 
AhrC, repressor of arg 
regulon 
22 304912 G -> A A -> T Substitution Glycosyl transferase 
family protein, 
putative 
22 505342 CGG -> 
TTT 
GG -> GL Substitution PTS system, 
trehalose-specific IIB 
component 
(EC2.7.1.69) 
22 1034607 G -> T 
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22 1721293 C -> A V -> L Substitution peptidase, U32 family 
small subunit [C1] 
22 2784215 A -> T 
  
Arc promoter 
24 1427979 A -> G I -> V Substitution Mobile element 
protein 
24 2513697 G -> A P -> L Substitution Two component 
sensor histidine kinase 
24 2784181 A -> G 
  
Arc promoter 
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Table 2.3 Oligonucleotides used in the RT-qPCR study 
 
Name Sequence Comments 
oLH1 CCT TAT GGC GAT GAT TGG 
TTT G 
Forward primer for S. aureus JE2 putA 
transcriptional analysis by RT-PCR 
oLH2 CCA GCA GGT TTC ACA 
AAT TCT T 
Reverse primer for S. aureus JE2 putA 
transcriptional analysis by RT-PCR 
oLH3 GGT CTT GGT AGA ACT 
GGG AAA T 
Forward primer for S. aureus JE2 rocD 
(SAUSA300_0187) transcriptional analysis by 
RT-PCR 
oLH4 CAA GTA CAG CAG ATA 
CAG GGT ATA A 
Reverse primer for S. aureus JE2 rocD 
(SAUSA300_0187) transcriptional analysis by 
RT-PCR 
oLH5 CTG TAG AGG ATA CTG 
CGA AAG T 
Forward primer for S. aureus JE2 arcB1 
transcriptional analysis by RT-PCR 
oLH6 GGA TGC CAA TCG TCT GTT 
AAT C 
Reverse primer for S. aureus JE2 arcB1 
transcriptional analysis by RT-PCR 
oLH7 CAT TTG AAA CAG CGG 
CTT ATG A 
Forward primer for S. aureus JE2 arcB2 
transcriptional analysis by RT-PCR 
oLH8 ACA CGA GCA GTA TCT 
TTG GTA G 
Reverse primer for S. aureus JE2 arcB2 
transcriptional analysis by RT-PCR 
oLH9 AAG AAC GCG ATG TGC 
ATT TG 
Forward primer for S. aureus JE2 argF 
transcriptional analysis by RT-PCR 
oLH10 AGC ACA CGT GCA GTA 
TCT TTA  
Reverse primer for S. aureus JE2 argF 
transcriptional analysis by RT-PCR 
oLH11 CAG AGC GAA TGA ATG 
TGG TAT TT 
Forward primer for S. aureus JE2 argGH 
transcriptional analysis by RT-PCR 
oLH12 TCA GCA GTA TCT GGT GTT 
TCT T 
Reverse primer for S. aureus JE2 argGH 
transcriptional analysis by RT-PCR 
oLH13 CGG TAG GTT CAG TAT 
CAG CAA TAA  
Forward primer for S. aureus JE2 rocF 
transcriptional analysis by RT-PCR 
oLH14 TTT CCA CTT GGT GAC TCT 
TCA G 
Reverse primer for S. aureus JE2 rocF 
transcriptional analysis by RT-PCR 
18 
 
oLH15 ATG TCT TTA CAC CTG GCT 
CAC  
Forward primer for S. aureus JE2 rocD 
(SAUSA300_0860) transcriptional analysis by 
RT-PCR 
oLH16 GGC CTG GTA AAT CCT CAT 
CAA  
Reverse primer for S. aureus JE2 rocD 
(SAUSA300_0860) transcriptional analysis by 
RT-PCR 
oLH17 CAA ATG ATC ACA GCA 
TTT GGT ACA G 
Forward primer for S. aureus JE2 gyrB 
(SAUSA300_0005) transcriptional analysis by 
RT-PCR.  Primer sequence taken from Borgogna 
2018 J Infect Dis.  Adenine residue in bold was 
not present in primer sequence listed in the 
publication. 
oLH18 CGG CAT CAG TCA TAA 
TGA CGA T 
Reverse primer for S. aureus JE2 gyrB 
(SAUSA300_0005) transcriptional analysis by 
RT-PCR.  Primer sequence taken from Borgogna 
2018 J Infect Dis.   
oLH19 GAA GAG CGT GAA AGT 
GGT AAA G 
Forward primer for detection of tpiA transcript by 
qPCR 
oLH20 GAT TGC CCA GAT TGG TTC 
ATA AG 
Reverse primer for detection of tpiA transcript by 
qPCR 
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Table 2.4 Probes used in the RT-qPCR study. 
Name Sequence 5' 
modification 
3' 
modification 
Primer pair Comments 
prLH1 TGA GAA 
GAT TAG 
CAG AAC 
GCC CAC 
A 
6-FAM BHQ-1 oLH1/oLH2 Taqman probe for 
detection of putA 
transcript by qPCR 
prLH2 ATG GAA 
TGG GAG 
CAA GTC 
GTT CCA  
HEX BHQ-1 oLH3/oLH4 Taqman probe for 
detection of rocD 
(SAUSA300_0187) 
transcript by qPCR 
prLH3 CAC CGG 
TAC ACC 
AGA 
GAA CTT 
CGC  
6-FAM BHQ-1 oLH5/oLH6 Taqman probe for 
detection of arcB1 
transcript by qPCR 
prLH4 TAC CCA 
TTT GAG 
AAC CTG 
TTG GCC 
C 
HEX BHQ-1 oLH7/oLH8 Taqman probe for 
detection of arcB2 
transcript by qPCR 
prLH5 AAG TTG 
CAG CGC 
ATG ATC 
AAG GTG  
6-FAM BHQ-1 oLH9/oLH10 Taqman probe for 
detection of argF 
transcript by qPCR 
prLH6 AGA 
AGA TCC 
TTA TGC 
TGC GCC 
ACC  
HEX BHQ-1 oLH11/oLH12 Taqman probe for 
detection of argGH 
transcript by qPCR 
prLH7 AGG TGT 
TAT TTG 
GTA TGA 
TGC ACA 
TGG TGA  
6-FAM BHQ-1 oLH13/oLH14 Taqman probe for 
detection of rocF 
transcript by qPCR 
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prLH8 TGG TAA 
TCC ACT 
TGC TTG 
TGC TGC  
HEX BHQ-1 oLH15/oLH16 Taqman probe for 
detection of rocD 
(SAUSA300_0860) 
transcript by qPCR 
prLH9 AAT CGG 
TGG CGA 
CTT TGA 
TCT AGC 
GAA AG 
6-FAM BHQ-1 oLH17/oLH18 Taqman probe for 
detection of gyrB 
transcript by 
qPCR.  Probe sequence 
was taken from 
Borgogna 2018 J 
Infect Dis. 
prLH10 CCT GCA 
ACA GCT 
TTC TTA 
ACT TGC 
TCA C 
HEX BHQ-1 oLH19/oLH20 Probe for detection of 
tpiA transcript by 
qPCR 
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3. Chapter 3: Results  
Staphylococcus aureus is a functional arginine auxotroph 
Based on the study by Nuxoll et al., the growth of S. aureus in media lacking arginine can 
be observed when glucose is not supplemented in the media. Complicating the picture, the growth 
of S. aureus was not observed when grown in a complete defined media lacking arginine without 
glucose (CDM-R) (Fig.3.1 A). However, upon extended incubation, we found that growth is 
consistently observed after 18-24 hours of growth. To test if this phenomenon is due to the potential 
induction of a particular metabolic pathway or selection of mutations, we streaked the colonies on 
Tryptic Soy Agar (TSA) following delayed growth on CDM-R and the growth pattern was tested 
in CDM-R.These colonies can rapidly grow on CDM-R (Fig.3.1 B) suggesting that S. aureus is a 
functional arginine auxotroph unless suppressor mutations facilitate the growth of this strain when 
exogenous arginine is not supplemented in the media. 
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Figure 3.1 Suppressor mutations  facilitate the growth of S. aureus in CDM-R.  Growth 
analysis of JE2 in (CDM) and (CDM-R). B. Growth analysis of JE2 suppressor mutant in (CDM-
R). Data represents means ± SEM of three biological replicates. 
 
 
  
0 10 20 30
0.1
1
Time(h)
O
D
6
0
0
JE2-CDM
JE2-CDM-R
23 
 
S. aureus arcB1 and ahrC mutations facilitate growth in CDM-R. 
Whole Genome Sequencing (WGS) of suppressors mutants identified two classes of mutations in 
the isolated colonies. Four isolates have mutations in the promoter region of the arcA1B1DC. 
Interestingly, two isolates have mutations in the Arginine pathway regulatory protein, AhrC. One 
of the isolates has a substitution mutation changing cysteine (Cys123) into phenylalanine (Fig.3.2). 
This cysteine residue is found at the dimer-trimer interface participating in the formation of an 
arginine binding pocket. Therefore, since AhrC was reported to be an L-arginine dependent 
repressor, this mutation will hinder the ability of AhrC to mediate repression of the arginine 
biosynthetic genes thus enabling the growth of S. aureus in complete defined media lacking 
arginine. The focus of this study will be on the ahrC isolate which will be referred to as the JE2 
ahrC mutant  
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Figure 3.2 JE2 suppressor mutation in the Arginine pathway regulatory protein, AhrC. 
Alignment of AhrC of the JE2 suppressor mutant against AhrC of wild type JE2.The alignment 
was done using VectorNTI align-X. Note the change of the cysteine into phenylalanine. 
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AhrC is the major regulator of arginine biosynthesis in S. aureus 
To confirm the growth observed in the JE2 ahrC mutant, growth analysis of ahrC markless deletion 
JE2 ΔahrC was performed. JE2 ΔahrC exhibits the same phenotype as JE2 ahrC mutant when 
grown in CDM-R confirming that the ahrC mutation facilitates the growth of S.aureus in the 
absence of extracellular arginine. Besides, since S. aureus encodes three ArgR-type transcriptional 
regulators, ArgR1 and ArgR2, and AhrC, to eliminate the possibility that ArgR1 and ArgR2 are 
complementing  AhrC function, growth of JE2 argR1:: NΣ and JE2 argR2:: NΣ was assessed in 
CDM-R. argR1:: NΣ does not grow in CDM-R and argR2:: NΣ exhibits a delayed growth reaching 
OD600 after 24 hours (Fig.3.3). Taken together, these data suggest that these three transcriptional 
regulators do not complement each other and that AhrC is the main repressor of arginine 
biosynthesis.  
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Figure 3.3 Mutation in argR1 and agrR2  does not facilitate S. aureus growth in CDM-R. 
Growth curve analysis of argR1:: NΣ, argR2:: NΣ and ΔahrC in CDM-R. Data represents means 
± SEM of three biological replicates. 
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Arginine biosynthesis is dependent upon proline in ahrC mutants 
S. aureus harbors the novel proline catabolic pathway as well as the canonical glutamate 
pathway to synthesize arginine. To investigate which metabolic pathway contributed to the growth 
of both the JE2 ahrC mutant and ΔahrC in CDM-R, transduction of putA, argC and argH was 
performed. The growth of the resulting mutants was evaluated in CDM-R. Mutation of putA and 
argH halted the growth of the JE2 ahrC mutant as well as ΔahrC. However, the mutation in argC 
did not affect the growth (Fig.3.4) To confirm these results, the JE2 ahrC mutant was grown in 
CDM-R in the presence of either 13C5-Pro or 13C5-Glu. 13C5-labelled arginine was detected in the 
presence of proline and not glutamate (Fig.3.5). These data strongly suggest that S. aureus relies 
on proline as a precursor to synthesize arginine and that unlike AhrC in Bacillus subtilis, AhrC in 
S. aureus appears to regulate arginine biosynthesis via proline with no repression being exerted on 
the argDCJB operon. 
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Figure 3.4  Proline catabolism facilitates  growth ahrC mutants in CDM-R.Growth curves 
analysis of ΔahrC/putA::NΣ,ΔahrC/argC:: NΣ , ΔahrC/argH:: NΣ, JE2 ahrC mutant/ putA::NΣ,JE2 
ahrC mutant/ argC:: NΣ, JE2 ahrC mutant/ argH:: NΣ in CDM-R. Data represents means ± SEM 
of three biological replicates. 
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Figure 3.5 Growth JE2 ahrC mutant is dependent upon arginine biosynthesis via proline. 
Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) of JE2 ahrC mutant grown 
in CDM-R in the presence of either 13C5-Proline or 13C5-Glutamate.Data represent active  peaks 
out of three biological replicates are displayed 
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AhrC functions to repress argGH and arcB1 in the absence of extracellular arginine.   
To investigate how AhrC regulates arginine biosynthesis in S.aureus, quantitative reverse 
transcription (RT-qPCR) was performed to assess the transcription of arginine biosynthetic genes 
in the JE2 ahrC mutant and ΔahrC when grown in CDM and CDM-R compared to wild type JE2 
in CDM.  Transcription of putA ,argD ,arcB1 ,arcB2 ,arg F,argG ,rocF, rocD were assessed.  A 
significant change in the gene expression of argG and arcB1 was observed with approximately 
3000 and 100 fold change, respectively, in ΔahrC when grown in CDM-R compared to wild type 
JE2 in CDM (Fig.3.6). Similar results were observed in the JE2 ahrC mutant with no change of 
argDCJB gene expression in both  ΔahrC and JE2 ahrC mutant. Therefore, the transcription 
analysis results demonstrate that in S. aureus, AhrC functions to repress argGH and arcB1 in 
absence of arginine allowing for arginine biosynthesis via proline. Indeed, as stated above, growth 
in CDM-R via an ahrC mutation is proline-dependent and glutamate-independent. In addition, our 
LC-MS/MS demonstrated the accumulation of  13C5-ornithine and 13C5-citrulline in the presence of 
13C5-proline and not glutamate (Fig. 3.7).  ArcB1 catalyzes the formation of citrulline by using 
ornithine as a substrate whereas citrulline is subsequently converted into arginine through the 
activity of ArgG and ArgH, further confirming our transcriptional data as well as that argGH and 
arcB1 facilitate the biosynthesis of arginine via proline. 
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A                                                                                            B 
 
 
 
Figure 3.6 ahrC mutation augments argGH and  arcB1 transcription allowing for arginine 
biosynthesis via proline. Quantitative reverse transcription PCR (RT-qPCR) assessing the 
expression of arginine biosynthesis genes in ΔahrC and JE2 ahrC mutant. A) Relative expression 
of argG, a transcriptional unit representing argGH operon, in both CDM and CDM-R. B) Relative 
expression of arcB1, a transcriptional unit representing arcA1B1DC operon, in both CDM and 
CDM-R. 
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Figure 3.7 ArcB1, ArgG, ArgH catalyzes the formation of arginine from proline. Liquid 
Chromatography with tandem mass spectrometry (LC-MS-MS) of JE2 ahrC mutant grown in 
CDM-R in the presence of either 13C5-Proline or 13C5-Glutamate.Accumulation of both A) ornithine 
and B) citrulline was detected in the presence of 13C5-Proline. Representative date from three 
biological replicates. 
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4.  Chapter 4: Discussion 
 
Historically, the extensive studies of the arginine biosynthetic pathway have led to the 
disclosure of multiple findings, which has set the basic features of metabolic regulation and brought 
forth numerous scientific notions such as repression, repressor, and regulon [12, 13, 31]. 
Publications identifying enzymes and genes which are necessary for arginine biosynthesis have 
brought insights of evolutionary significance [6]. The study on the arg regulon has led to multiple 
discoveries including gene duplication, the mechanism involved in the reactivation of silent genes 
through the generation of tandem repeats, and the precise function of a transposon as a mobile 
promoter as well as the origin of divergent promoters [32-35]. 
Despite harboring the biosynthetic capability to synthesize arginine, S. aureus exhibits 
auxotrophy for arginine when grown on a defined laboratory media lacking arginine [36]. We 
demonstrated that growth in media lacking arginine can be selected after extended incubation. We 
have shown that this delayed growth is due to the selection of mutations in ahrC loci. AhrC is a 
transcriptional regulator that represses arginine biosynthesis when arginine is present by binding to 
an operator site called the ARG box found upstream of arginine biosynthetic genes 
(argJBCDFGH). Experimental evidence indicates that this mechanism of regulation is conserved 
among gram-positive as well as gram-negative bacteria. our data provided evidence that AhrC in 
S. aureus regulates arginine biosynthesis via proline and not glutamate. Indeed, mutations in putA 
and argH have completely abrogated the growth of JE2 ahrC mutant as well as ΔahrC in CDM-R 
while a mutation in argC did not affect the growth. Furthermore, our LC-MS/MS demonstrated the 
accumulation of 13C5-arginine when the JE2 ahrC mutant was grown in CDM-R  in the presence 
of 13C5-proline and not 13C5-glutamate further confirming that AhrC functions to regulate arginine 
biosynthesis via proline and not glutamate. Also, our transcriptional analysis revealed that AhrC 
represses argGH and arcB1 with no change in gene expression of argDCJB. Our LC-MS/MS 
analysis supports these data with the accumulation of ornithine and citrulline was observed in the 
34 
 
presence of 13C5-proline suggesting that proline is being catabolized into arginine by the enzymatic 
activity of arcB1, argG and argH. These data together suggest that AhrC functions to repress 
argGH transcription allowing for arginine biosynthesis via proline. These data also suggest the 
presence of an additional transcriptional regulator functioning to repress the production of arginine 
from glutamate. Further, results from our laboratory demonstrate that a putA mutant does not grow 
in defined media lacking arginine indicating that the glutamate pathway is inactive in vitro. 
However, the selection of putA suppressor mutants that can grow in a media lacking arginine has 
allowed us to identify that the glutamate pathway is induced when SpoVG, a DNA binding protein 
is mutated (data not shown). However, it is still unknown how SpoVG regulates arginine 
biosynthesis and why S. aureus has adopted a novel pathway via proline for arginine biosynthesis. 
Using proline as a precursor suggests that S. aureus is maintaining the glutamate pool to be used 
by other biosynthetic pathways. It is well documented that glutamate is an important precursor to 
produce siderophores. Siderophores are iron scavenging proteins secreted by S. aureus to overcome 
the iron limitation. S. aureus harbors two siderophores, Staphyloferrin A (SA) and Staphyloferrin 
B (SB). SA production relies on TCA cycle activity, however, interestingly, SB production is 
independent of TCA cycle activity and all its precursors are generated through the metabolism of 
glutamate. This independence from the TCA cycle highlights the importance of glutamate in the 
production of staphyloferrin B, which was shown to be more important in vivo than the other 
siderophores [37]. Iron sequestration from the host contributes to S. aureus virulence and its ability 
to cause severe and invasive infection. Hence, the exploitation of glutamate by the arginine 
biosynthetic pathway may come at a cost, making S. aureus less virulent and attenuated for 
pathogenesis. 
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5. Chapter 5: Concluding Remarks and Future Directions. 
S. aureus can invade multiple organ systems causing infection in diverse metabolic 
environments. To survive and proliferate within the host, S. aureus has evolved to fine-tune its 
metabolism to utilize carbon sources unique to each niche. Several studies have been conducted on 
S. aureus metabolism, however, little emphasis has been given on how arginine metabolism 
facilitates the proliferation of this organism during infection. Investigating important metabolic 
pathways is crucial and leads to the development of therapeutic that disrupts critical metabolic 
pathways and limits the growth of this highly adaptable pathogen. 
It has been known for decades that S. aureus is auxotrophic for many amino acids including 
arginine.  We identified that after extended incubation, S. aureus can be trained to grow in a defined 
media lacking arginine via the selection of mutations. We have also demonstrated that arginine 
biosynthesis via proline is under repression, with AhrC repressing argGH and arcB1. Interestingly, 
the selected mutants still do not synthesize arginine via glutamate. However, using a mutant unable 
to synthesize arginine via proline, we identified mutants able to synthesize arginine via glutamate. 
Through the selection of suppressors mutants, we identified SpoVG as a potential transcriptional 
regulator of glutamate-mediated arginine biosynthesis. In the future study, we will determine how 
SpoVG regulates arginine biosynthesis and if SpoVG interacts with AhrC to mediate effective and 
strong regulation. In addition, the biosynthesis of arginine via glutamate is tightly regulated in S. 
aureus. It is unclear when or if S. aureus derepresses the glutamate biosynthetic pathway during 
host invasion. In our future study, we will also determine the impact of the induction of the 
glutamate pathway on the ability of S. aureus to colonize and survive within different niches. The 
generated data will provide insight into whether the differential regulation selected within S. aureus 
is beneficial or if it negatively impacts other metabolic strategies employed by S. aureus to thrive 
in nutrient-limited environments. 
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In conclusion, S. aureus appears to regulate the arginine biosynthetic pathway differently. 
How this regulation of biosynthetic pathway impacts S. aureus virulence and persistence has not 
been determined to date. Therefore, further studies are required to understand how metabolic 
regulation is intricately associated with the ability of S. aureus to survive within a hostile 
environment and how S.aureus tailors niche-specific biosynthesis regulation by modulating the 
function of transcriptional regulators. 
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